Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 10,420
+30 (0.29%)
At close: Aug 11, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 141.15 billion as of August 12, 2026. Its market cap has decreased by -42.75% in one year.
Market Cap
141.15B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
10,420.00
ChartMarket Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 141.15B, an increase of 32.90%. That is a compound annual growth rate of 3.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 141.15B | -19.61% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Genome & Company | 217.57B |
| Kanaph Therapeutics | 200.71B |
| NIBEC | 197.69B |
| Y-Biologics | 175.18B |
| Bio Solution | 161.79B |
| Prestige Biologics | 154.88B |
| TiumBio | 151.09B |
| ISU Abxis | 145.97B |